TCS selected by QIAGEN to insights solutions in life sciences, molecular diagnostics

16 Jun 2022 Evaluate

Tata Consultancy Services (TCS) has been selected by QIAGEN, a leading global provider of Sample to Insights solutions in life sciences and molecular diagnostics, as the strategic partner for its cloud transformation journey. QIAGEN is investing in an ambitious cloud transformation to address new challenges of the post-pandemic era. QIAGEN partnered with TCS for its deep contextual knowledge of the company’s infrastructure, applications, and systems, vast experience in the life sciences industry as well as its proven technology expertise.

TCS will migrate the company’s workloads from its legacy data center to Microsoft Azure and build a new scalable digital core as a foundation for better ways of working. TCS’ team of cloud solution experts will work closely with QIAGEN to design, implement and manage a cloud first model. The new digital core will help improve internal and external collaboration, enabling greater innovation, and enhanced customer experience. Additionally, it will improve operational agility and resilience, drive efficiency, reduce QIAGEN’s carbon footprint and support its journey to net zero.

TCS is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for over 50 years.

TCS Share Price

3125.05 -21.05 (-0.67%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3125.05
Infosys 1640.45
HCL Tech. 1694.45
Wipro 236.70
Tech Mahindra 1743.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×